Bemrist Breezhaler is a medicine that is used to keep the airways open in adults and children aged 12 years and older whose asthma is not adequately controlled with inhaled corticosteroids and inhaled short acting beta-2 agonists. Bemrist Breezhaler is used for maintenance (regular) treatment. The medicine contains the active substances indacaterol and mometasone.
Therapeutic Indication
### Therapeutic indication Bemrist Breezhaler is indicated as a maintenance treatment of asthma in adults and adolescents 12 years of age and older not adequately controlled with inhaled corticosteroids and inhaled short acting beta2-agonists.
Therapeutic Area (MeSH)
ATC Code
R03AK
ATC Item
肾上腺素能药结合糖皮质激素或者其他抗胆碱能药物
Pharmacotherapeutic Group
Drugs for obstructive airway diseases
Active Substance (Summary)
INN / Common Names
EMA Name
Bemrist Breezhaler
Medicine Name
Bemrist Breezhaler
Aliases
N/ANo risk management plan link.
